Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/30501
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDas, Siddhartha-
dc.contributor.authorMartinez, Leobarda Robles-
dc.contributor.authorRay, Suparna-
dc.date.accessioned2015-02-11T04:29:52Z-
dc.date.available2015-02-11T04:29:52Z-
dc.date.issued2014-12-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/30501-
dc.description512-519en_US
dc.description.abstractPhospholipid remodeling and eicosanoid synthesis are central to lipid-based inflammatory reactions. Studies have revealed that membrane phospholipid remodeling by fatty acids through deacylation/reacylation reactions increases the risk of colorectal cancers (CRC) by allowing the cells to produce excess inflammatory eicosanoids, such as prostaglandins, thromboxanes and leukotrienes. Over the years, efforts have been made to understand the lipid remodeling pathways and to design anti-cancer drugs targeting the enzymes of eicosanoid biosynthesis. Here, we discuss the recent progress in phospholipid remodeling and eicosanoid biosynthesis in CRC.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBB Vol.51(6) [December 2014]en_US
dc.subjectColon canceren_US
dc.subjectArachidonic aciden_US
dc.subjectLipid remodelingen_US
dc.subjectCyclooxygenaseen_US
dc.subjectLipooxygenaseen_US
dc.subjectProstaglandinsen_US
dc.subjectLeukotrienesen_US
dc.titlePhospholipid Remodeling and Eicosanoid Signaling in Colon Cancer Cellsen_US
dc.typeArticleen_US
Appears in Collections:IJBB Vol.51(6) [December 2014]

Files in This Item:
File Description SizeFormat 
IJBB 51(6) 512-519.pdf201.92 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.